The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.

Rémy SchwarzerThomas ReibergerMattias MandorferDanijel KivaranovicSilvia HametnerStephanie HametnerRafael PaternostroBernhard ScheinerJenifer Schneeweiss-FriedlMichael TraunerRainer SchoeflAndreas Maieron

Published in: Journal of gastroenterology (2019)

VITRO is a valuable prognostic tool for estimating the risk of decompensation and mortality in patients with compensated cirrhosis-including the setting after hepatitis C eradication.

Keyphrases

cardiovascular events
risk factors
cardiovascular disease